The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://teapaw.org/t.co/qpcDlbaOSx
Global
Joined August 2015
- Tweets51K
- Following80
- Followers32.9K
- Likes4.5K
VectorY added $83.5M to its Series A to fund a gene therapy that makes antibodies against ALS-linked proteins in the brain. endpoints.news/vectory-bags-…
1,190
With medicines spending up, the UK's science minister is calling on life sciences companies to invest on home soil. endpoints.news/uk-science-mi…
2
985
Democrats asked every drugmaker with a Trump MFN deal for its unredacted agreement, a sign of the oversight coming after their midterm wins. endpoints.news/democrats-ram…
Merck KGaA's Pimjetmi, licensed from China's Abbisko, won FDA approval for rare noncancerous joint tumors. endpoints.news/merck-kgaa-la…
2
1,105
RFK Jr. is bullish on MAHA's future despite GOP midterm losses, saying the Senate "no longer has any leverage over me." endpoints.news/despite-midte…
1
1,095
The White House is pressing ahead with Heidi Overton's FDA nomination, working senators for votes before Democrats take the Senate. endpoints.news/white-house-s…
1,271
Bayer's stroke prevention drug asundexian won FDA approval, becoming the first factor XIa inhibitor on the market. endpoints.news/bayer-wins-fd…
Beam's base-edited sickle cell therapy succeeded in a Phase 1/2 study, putting a third one-time therapy for the disease within reach. endpoints.news/beam-says-bas…
1,182
Trump's MFN deals are forcing drugmakers to choose between lower prices, pushing other countries to pay more or launching only in the US. endpoints.news/trumps-drug-p…
The Pentagon removed WuXi AppTec from its Chinese military list, but the company could still be relisted as its court case continues. endpoints.news/us-government…
1
1,046
Lilly-backed Oyster Therapeutics raised $60M to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer's. endpoints.news/london-startu…
#AHA26: Marea's triglyceride drug cut levels without raising blood sugar, which could give it an edge in diabetic patients. endpoints.news/aha26-mareas-…
7
1,858
#AHA26: Lilly will seek approval of obesity pill Foundayo in sleep apnea after a Phase 3 win. endpoints.news/aha26-lilly-g…
2
1,642
Heidi Overton, Trump’s pick to lead the FDA, is waiting for confirmation. But Nick Shipley, founder of Cronus Consulting, isn’t sure the White House will spend political capital to push her through during the lame duck. Catch up on Post-Hoc Live for our breakdown of how the midterm results could impact federal healthcare agencies. youtube.com/live/ghjQxZj1bWQ
1,148
#AHA26: Novo and Novartis' heart drugs worked as designed but didn't prevent CV events, raising doubts about the science behind them. endpoints.news/aha26-the-sim…
1
1,068
The FDA is investigating a "serious risk" of cancer linked to Novartis' Zolgensma, days after the company disclosed seven new tumor cases. endpoints.news/fda-launches-…
Argenx is buying macrocycle biotech Unnatural Products for $550M upfront, adding oral peptide capabilities to its antibody engineering. endpoints.news/argenx-to-acq…
The FDA says its is looking into a “serious risk” of cancer linked to Novartis’ spinal muscular atrophy gene therapy Zolgensma, following 7 new cases: endpoints.news/fda-launches-…
Moderna posted its first profitable quarter in two years on international Covid vaccine sales, as its cancer vaccine spending grows. endpoints.news/moderna-notch…
6
1,990
Sarepta won't resume enrollment in Elevidys' confirmatory Phase 3 trial, on hold since a second patient death last year. endpoints.news/sarepta-quits…
1
4
1,913